Event-Driven Stocks

Icosavax, Inc.

Healthcare · Biological Products, (No Diagnostic Substances) · DE · SEC filings ↗ · Compare ⊕

Signs3 good4 warningdetails ↓

Financials

SEC XBRL · annual
 FY22FY21FY20
Revenue$582,000$7.8M$1.6M
Operating income−$95.1M−$65.9M−$18.7M
Net income−$91.8M−$67.0M−$18.9M
Total assets$238.7M$287.6M$16.2M
Total liabilities$20.5M$9.4M$12.8M
Equity$218.2M$278.2M−$26.7M
EPS (diluted)$-2.31$-3.73
Shares out.39.7M39.2M2.6M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2022
Operating margin
−16333.0%
Net margin
−15766.0%
Return on equity
−42.1%
Return on assets
−38.4%
Return on capital (ROCE)
−42.3%
Liabilities / assets
8.6%
Debt / equity
0.09×
Book value / share
$5.49
Revenue growth (YoY)
−92.5%
Net income growth (YoY)

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2022
Altman Z″ (distress)
11.73safe
Accruals / assets
12.6%clean
Piotroski F-Score
1/9weak

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
40
/ 100
Profitability 0Growth 0Catalyst 33Earnings quality 67Financial strength 100

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →

Signs

4 warning3 good
  • Operating losses (negative operating margin)
  • Reported a net loss
  • Revenue declined year-over-year
  • Negative operating cash flow
  • Conservative leverage (liabilities < 50% of assets)
  • Clean earnings (low accruals)
  • Altman Z″ in the safe zone

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

Insider transactions

SEC Form 4 · most recent
0 acquisitions11 disposalsnet 856,010 shares · last 11
InsiderDateTypeSharesPrice
Ra Capital Management, L.P.DirectorFeb 19, 2024U5,543
Simpson Adam K.Feb 19, 2024U358,657
Veneman Ann MFeb 19, 2024U11,209
Cearley CassiaFeb 19, 2024U131,799
Fields HeidiFeb 19, 2024U11,376
Wassil JimFeb 19, 2024U3,695
Russo Thomas JosephFeb 19, 2024U39,367
Shiver John W.Feb 19, 2024U8,066
Mcdade MarkFeb 19, 2024U55,786
Kanesa-Thasan NiranjanFeb 19, 2024U223,980
Simpson Adam K.Officer — Chief Executive OfficerFeb 1, 2024Gift6,532$0.00

Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (1)

Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.